Skip to content
Therapy But Better – Lifestyle
Author:
Risen Pharma Tech Co., Ltd
Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
May 19, 2026